#generalIR

As of February 27, 2026, National Indemnity Company, a wholly owned subsidiary of Berkshire Hathaway Inc., increased its voting rights ratio in our company’s shares from 9.54% to 10.07%, becoming the largest shareholder.

In February 2026, margin transaction loans amounted to 550,539 hundred million yen, loans of securities were 294,123 hundred million yen, and net short stock balance was 123,251 hundred million yen.

The Company has decided to participate as an auxiliary defendant in the shareholder derivative lawsuit and will appropriately counter the plaintiff shareholders' claims as they are judged to be unfounded.

We announce that as of February 25, 2026, the voting rights holding ratio of Silchester International Investors LLP decreased from 10.25% to 9.23%, and the number of shares owned decreased from 12,596,100 shares to 11,346,100 shares.

Sold 5 listed securities between February 17 and 25, 2026, recording special profit of 1,818 million yen. To be reflected in fiscal year ending March 2026 financial statements.

ZOZO, Inc. entered into a 12.5 billion yen commitment line agreement on March 13, 2026, to prepare for future M&A funding needs.

Asuka Pharmaceutical Holdings Co., Ltd. has resolved to transition to a company with an audit and supervisory committee, subject to approval at the 5th Annual General Meeting of Shareholders scheduled for June 24, 2026.

On March 4, 2026, Frontier Real Estate Investment Corporation executed a borrowing of 1,000 million yen from The Bank of Tokyo-Mitsubishi UFJ, Ltd., and plans to repay the same amount of long-term debt executed on March 3, 2025.

On February 12, 2026, our company was sued by NHP Solution Corporation in the Tokyo District Court for contract payment claims totaling approximately JPY 311,550,000.

As of February 18, 2026, Dalton Investments Inc.'s voting rights percentage increased from 9.76% to 10.62%, with the number of shares owned rising from 16,642,700 shares to 18,119,200 shares.

Scheduled to record an extraordinary profit of 5.5 billion yen from the sale of investment securities between December 2025 and February 2026. 1.14 billion yen has already been recorded in the third quarter of the fiscal year ending March 2026.

On February 25, 2026, one listed investment security held was sold, resulting in a gain on sale of investment securities of 608 million yen. No changes to earnings guidance.